Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/4f/54/f6/4f54f6f2-67fb-98c5-38a0-8c4ba71cc4cd/mza_2911635359453061199.jpg/600x600bb.jpg
The ConcertAI Podcast
ConcertAI
21 episodes
7 months ago
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
Show more...
Life Sciences
Science
RSS
All content for The ConcertAI Podcast is the property of ConcertAI and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
Show more...
Life Sciences
Science
Episodes (20/21)
The ConcertAI Podcast
From Biopsy to Breakthrough: Real-world Genomics in Early-Stage Oncology Trials
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
Show more...
7 months ago
21 minutes

The ConcertAI Podcast
The Future of Drug Development: AI, RWD, and Regulatory Insights feat. Evidera's Ariel Berger
In this episode of The ConcertAI Podcast, Jeff Elton, CEO of ConcertAI, engages with Ariel Berger, Executive Director of Integrated Solutions of Evidera, part of the PPD™ clinical research business of Thermo Fisher Scientific, to explore the innovative uses of real-world data (RWD) in regulatory settings, particularly in oncology. They discuss the critical role of RWD in shaping clinical trials and supporting regulatory decisions, emphasizing its growing importance in the regulatory approval ...
Show more...
7 months ago
42 minutes

The ConcertAI Podcast
Accelerating Healthcare Innovation with NVIDIA feat. Rory Kelleher
In the season three opener of The ConcertAI Podcast, our guest Rory Kelleher (Senior Director, Global Head of Business Development, Life Sciences) from NVIDIA delves into the transformative role of AI in healthcare and life sciences. With a rich background at NVIDIA, Rory shares insights into NVIDIA’s journey from a GPU manufacturer to a leader in AI computation. This episode explores NVIDIA’s initiatives like the Clara platform, which seamlessly integrates AI into medical imaging and genomic...
Show more...
8 months ago
44 minutes

The ConcertAI Podcast
Prostate Cancer Awareness with Steve Osunsami: Screening, Survival, and Breaking Stigmas
In this compelling episode of The ConcertAI Podcast, host Jeff Elton sits down with ABC's senior national correspondent, Steve Osunsami, to discuss the critical importance of prostate cancer screening and awareness. Steve shares his personal journey with prostate cancer, from initial diagnosis at age 41 to treatment and recovery. He highlights the significance of early detection, particularly for high-risk groups such as African American men, and the life-saving potential of regular PSA testi...
Show more...
1 year ago
40 minutes

The ConcertAI Podcast
Breaking New Ground in Prostate Cancer Research feat. Jennifer Rider and Kathryn Penney
September marks Prostate Cancer Awareness Month, and to honor this, our latest episode of the ConcertAI Podcast features a special session with top urological cancer specialists. Host Jeff Elton welcomes Jennifer Rider and Kathryn Penney to our studio in Harvard Square, Cambridge, MA. Both guests are distinguished cancer epidemiologists who bring a wealth of knowledge and experience in prostate cancer research. In this episode, you will hear about the personal journeys of our guests int...
Show more...
1 year ago
24 minutes

The ConcertAI Podcast
CancerLinQ's Transformational Role in Oncology with Dr. Robert Miller
Jeff Elton sits down with Dr. Robert Miller, Chief Medical and Science Officer at CancerLinQ, to unpack the integration of real-world data and AI in oncology care. Dr. Miller shares his journey from community practice to shaping CancerLinQ, revealing insights into the network's growth and its pivotal role in improving patient care. The episode delves into the transformation of quality measures, the burgeoning role of electronic health records, and the automation of data to enhance the quality...
Show more...
1 year ago
34 minutes

The ConcertAI Podcast
Evolution in Oncology Care feat. Dr. George W. Sledge, Jr.
Jeff Elton, CEO of ConcertAI, and George Sledge, CMO of Caris Life Sciences, embark on an insightful journey through the advancements in oncology. They explore the transformative power of molecular diagnostic testing and how comprehensive data sets are revolutionizing personalized medicine. Delving into topics like the rise of liquid biopsies, which enable non-invasive, next-gen sequencing, they highlight the potential for easier and safer tumor monitoring. Challenges like the limitations of ...
Show more...
1 year ago
30 minutes

The ConcertAI Podcast
Next-Gen Oncology: Caris Life Sciences & ConcertAI's Vision feat. Dr. David Spetzler
In this engaging episode, David Spetzler, President of Caris Life Sciences, and Jeff Elton, CEO of ConcertAI, discuss the transformative power of combining clinical insights and advanced AI technologies to revolutionize patient care in oncology. Highlighting their collaborative efforts, they emphasize the critical role of comprehensive data analysis, from leveraging longitudinal clinical records to employing next-generation sequencing for personalized treatment strategies. The conversation un...
Show more...
1 year ago
25 minutes

The ConcertAI Podcast
Empowering Community Oncology: Challenges & Innovations
The second episode of The ConcertAI Podcast features Dr. Sibel Blau and Caroline Merillat, key figures in the Quality Cancer Care Alliance (QCCA) and creators of Exigent. This initiative aims to improve clinical research in community oncology, making trials more accessible and reflective of standard care populations. Dr. Blau, motivated by a dream to cure cancer, emphasized the importance of maintaining the independence of oncology practices for superior patient care. Merillat, with extensive...
Show more...
1 year ago
36 minutes

The ConcertAI Podcast
Real-World Data in Oncology: Navigating the New Frontiers feat. Jennifer Rider
In this captivating episode of The ConcertAI Podcast, we dive deep with Jennifer Rider, a renowned cancer epidemiologist. Jennifer shares her journey from academia to the dynamic world of real-world data (RWD) and its vital role in oncology research. We explore how RWD is transforming the landscape of prostate cancer studies and its increasing importance in regulatory decision-making. Discover how the field of RWD has evolved and its pivotal contributions to the development and application o...
Show more...
1 year ago
33 minutes

The ConcertAI Podcast
Season 2 Introduction
We're back with The ConcertAI Podcast for Season Two! In our first episodes, we delve deep into RWE's role in regulatory applications, such as designing registrational clinical trials and developing robust data sets that shape trial designs and submissions. We're exploring the evolving landscape of efficacy, safety, and the use of external control arms, especially in light of recent FDA guidance. But that's not all. Season Two also highlights incredible progress in clinical trial networks a...
Show more...
1 year ago
2 minutes

The ConcertAI Podcast
The Future of Digital Pathology with PathAI feat. Dr. Andy Beck
In this episode, we're thrilled to have Dr. Andy Beck, the Co-founder and CEO of PathAI, one of the leading digital pathology companies, as our guest. Digital pathology is transforming the accessibility of decision rules and decision augmentation, creating translational assets and changing how clinical development occurs. Dr. Beck shares insights on the progress and life of digital pathology, and how it's transforming healthcare. With the level of data and insights available to medical profe...
Show more...
2 years ago
36 minutes

The ConcertAI Podcast
Exploring the Future of Clinical Trials pt. 1 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter
A 2-Part Special with Bristol Myers Squibb on the Digitally Accelerated Clinical Trial (DACT) Model. In part 1, we will be joined by Marissa Co, Vice President of R&D Business Insights & Analytics, and Gaelan Ritter, Head of Analytics Innovation and Digital Health, who shed light on the exciting ways clinical trials are evolving and improving patient outcomes. The team at Bristol Myers Squibb will be discussing their groundbreaking work using the Digitally Accelerated Clinical ...
Show more...
2 years ago
33 minutes

The ConcertAI Podcast
Exploring the Future of Clinical Trials pt. 2 feat. Bristol Myers Squibb's Marisa Co and Gaelan Ritter
In this episode, we continue to discuss the historic challenges of running clinical trials in community settings and how AI-powered patient identification tools and semi-automated data solutions are changing the game. Bristol Myers Squibb's Marisa and Gaelan share how their collaboration with ConcertAI on the Digitally Accelerated Clinical Trial Solution (DACT) is lowering the burden on patients and sites, and increasing the number of clinical trial types that can be run in community se...
Show more...
2 years ago
25 minutes

The ConcertAI Podcast
Exploring Globalization and the Power of Biopharma Innovation feat. Jitendra Gupta
ConcertAI is grateful to have a presence in a geography with such a fast pace of technical innovation, and is excited for the future. Tune in to the latest episode of The ConcertAI Podcast, hosted by CEO Jeff Elton! This week's episode explores the topic of globalizing healthcare and biopharma technical innovation. Jeff and Jitendra Gupta talks about what it really means to be a global company, and the amazing progress that India has made in advancing the healthcare and biopharma technology i...
Show more...
2 years ago
23 minutes

The ConcertAI Podcast
Revolutionizing Medical Imaging Using AI feat. TeraRecon's Dan McSweeney
In this episode of the ConcertAI podcast, join our CEO Jeff Elton and Dan McSweeney, President of TeraRecon, ConcertAI's digital imaging solution, for an informative and engaging discussion. TeraRecon is a leading solution for three-dimensional radiological interpretation, but what makes them stand out is their novel approach of integrating AI directly into care delivery models. Jeff and Dan explore the unique position of TeraRecon in the healthcare workflow and how their neutrality set...
Show more...
2 years ago
21 minutes

The ConcertAI Podcast
Real World Data: Unlocking the Power of Patient Insights feat. Catherine Richards
Don't miss out on the latest episode of The ConcertAI Podcast featuring Catherine Richards, ConcertAI's chief data officer! Join us as we dive into the state of the field of real world data, why it's transforming, and how research is now enabled because of it. Tune in to gain more understanding about data sets and analyses derived from real world data. Click the link to listen now! Website www.ConcertAI.com LinkedIn www.linkedin.com/company/concertai/ Twitter www.twitter.com/concertai
Show more...
2 years ago
33 minutes

The ConcertAI Podcast
Clinical Development Technologies feat. Luke Dunlap
On this episode of The ConcertAI Podcast, we're joined by SVP of Clinical Development Technologies, Luke Dunlap. Luke and Jeff discuss the experience and transformation about how clinical trials are being conducted with some of the newest technologies and the value that's being realized. Take a deeper dive into our end-to-end software platform, Digital Trial Solutions, is being used to conduct pharmaceutical studies at clinical research sites and how it is subsequently reducing pa...
Show more...
2 years ago
29 minutes

The ConcertAI Podcast
Trial Diversity feat. Warren Whyte
On this episode we are joined by Dr. Warren Whyte. Dr. Whyte heads up ConcertAI’s health equity and trial diversity initiatives through the ERACE (Engaging Research to Achieve Cancer Care Equity) program . As a leader in this field, his work and the work of his team has influenced all of what ConcertAI brings to clients, customers, and biopharma partners. This includes the integration of SDOH with all of our datasets - a first-in-class for anybody in the RWD Industry. His work also influenced...
Show more...
2 years ago
29 minutes

The ConcertAI Podcast
Multi-modal Data feat. Claudio D'Ambrosio
On our first episode, special guest Claudio D'Ambrosio covers the topic of multi-modal data in biomedical research. Multi-modal data can allow some of the deepest most advanced research questions to be answered. We start with the questions and then we bring together layers of different data, of different origin, that surround the patient in service of that particular question. This will change and transform how we develop and test hypothesis and will accelerate early phase trial activities.&n...
Show more...
2 years ago
17 minutes

The ConcertAI Podcast
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...